| Health / Medical Topics |
Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100
A fusion protein containing a modified form of human T-cell receptor (TCR) specific for the gp100 antigen and fused to an anti-CD3 single-chain antibody fragment, with potential antineoplastic activity. Upon direct intratumoral administration of IMCgp100 into the melanoma lesion, the TCR moiety of this agent targets and binds to the tumor associated antigen (TAA) gp100 presented on the melanoma tumor cell; the anti-CD3 fragment moiety binds to CD3- expressing T lymphocytes, thereby selectively cross-linking tumor cells and T-lymphocytes. This may lead to the recruitment of cytotoxic T lymphocytes (CTL) to the T lymphocyte/tumor cell aggregates and result in CTL-mediated death of gp100-expressing melanoma cancer cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
The determination of the amount of monoclonal protein present in a sample.
An antibody found in unusually large amounts in the blood or urine of people with multiple myeloma and other types of plasma…
A plasma cell neoplasm characterized by the deposition of immunoglobulin in tissues, resulting in impaired organ function. It includes the following entities:…
A benign condition in which there is a higher-than-normal level of a protein called M protein in the blood. Patients with monoclonal…
A laboratory test result indicating the presence of an abnormally high level of monoclonal immunoglobulins in the blood or urine.
A condition in which a higher-than-normal number of identical B cells are found in the blood. People with monoclonal B-cell lymphocytosis may…
